Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.14B 906M 792M 731M 674M 1.27B 87.27B 1.3B 8.73B 3.44B 42.74B 3.4B 3.33B 147B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.02B 1.04B 905M 835M 770M 1.45B 99.7B 1.48B 9.98B 3.92B 48.83B 3.89B 3.8B 168B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-4.26%
1 week-0.22%
Current month+3.69%
1 month+5.63%
3 months-12.96%
6 months+3.93%
Current year+3.45%
1 week 4.49
Extreme 4.49
4.83
1 month 4.21
Extreme 4.21
4.91
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Director/Board Member 58 2007-12-24
Chairman 56 2026-03-26
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Chairman

296,500 0.0381%
9/18/20 Sell

Director

3,670,000 0.4719%
Change 5-day change 1-year change 3-year change Capi.($)
-4.26%-0.22%-16.04%-45.52% 906M
-1.32%+5.33%-8.55%-5.18% 13.54B
-3.30%+9.97%-27.67%-49.81% 5.27B
-2.47%+7.14%+0.62%-4.09% 4.72B
-5.06%+6.38%+8.55%-32.43% 4.07B
-2.65%+2.32%+4.01%-8.76% 3.75B
0.00%+9.56%-4.89%-3.35% 3.57B
-3.45%+9.23%-5.06%+7.03% 3.39B
-3.77%+0.45%-13.12%-22.74% 2.42B
-2.82%+3.13%-1.88%+49.73% 1.86B
Average -2.91%+2.18%-6.40%-11.51% 4.35B
Weighted average by Cap. -2.47%+2.98%-6.74%-11.69%

Financials

2024 2025
Net sales 3.83B 564M 493M 455M 419M 791M 54.35B 808M 5.44B 2.14B 26.62B 2.12B 2.07B 91.63B 3.05B 450M 393M 363M 334M 630M 43.31B 644M 4.34B 1.71B 21.21B 1.69B 1.65B 73.03B
Net income 33.62M 4.96M 4.33M 4M 3.69M 6.95M 478M 7.1M 47.81M 18.81M 234M 18.63M 18.22M 805M -104M -15.4M -13.46M -12.42M -11.44M -21.57M -1.48B -22.05M -148M -58.37M -726M -57.82M -56.56M -2.5B
Net Debt 1.4B 207M 181M 167M 154M 289M 19.9B 296M 1.99B 783M 9.74B 776M 759M 33.54B 875M 129M 113M 104M 95.92M 181M 12.43B 185M 1.24B 489M 6.09B 485M 474M 20.95B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-07-17 CN¥4.500 -4.26% 11,552,400
26-07-16 CN¥4.700 -1.05% 10,770,900
26-07-15 CN¥4.750 +3.04% 14,747,703
26-07-14 CN¥4.610 +1.10% 10,158,604
26-07-13 CN¥4.560 +1.11% 12,556,600

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock